Sitagliptin
Cat.No:IS0180 Solarbio
CAS:486460-32-6
Molecular Formula:C16H15F6N5O
Molecular Weight:407.31
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Metabolic Enzyme & Protease > SitagliptinCAS:486460-32-6
Molecular Formula:C16H15F6N5O
Molecular Weight:407.31
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 486460-32-6 |
| Name | Sitagliptin |
| Molecular Formula | C16H15F6N5O |
| Molecular Weight | 407.31 |
| Solubility | Soluble in Water ≥10mg/mL;Soluble in DMSO ≥25mg/mL(Need ultrasound or water bath) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 690-730-1 |
| MDL | MFCD19684081 |
| SMILES | O=C(N1CC2=NN=C(C(F)(F)F)N2CC1)C[C@H](N)CC3=CC(F)=C(F)C=C3F |
| InChIKey | MFFMDFFZMYYVKS-SECBINFHSA-N |
| InChI | InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1 |
| PubChem CID | 4369359 |
| Target Point | Dipeptidyl Peptidase (DPP) |
| Passage | Metabolic Enzyme&Protease |
| Background | Sitagliptin is a potent DPP4 inhibitor |
| Biological Activity | Sitagliptin 是一种有效的 DPP4 抑制剂,在 Caco-2 细胞中,IC50 值为 19 nM。[1-5] |
| Data Literature Source | [1]. Thomas,L.,et al. (R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356),a novel xanthine-based dipeptidyl peptidase 4 inhibitor,has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors. J Pharmacol Exp Ther. 2008 Apr;325(1):175-82. [2]. Kim,S.J.,et al.,Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes,2009. 58(3): p. 641-51. [3]. Sangle,G.V.,et al.,Novel biological action of the dipeptidylpeptidase-IV inhibitor,sitagliptin,as a glucagon-like peptide-1 secretagogue. Endocrinology,2012. 153(2): p. 564-73. [4]. Kim,S.J.,et al.,Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes,2008. 57(5): p. 1331-9. [5]. Beconi,M.G.,et al. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs. Drug Metab Dispos,2007. 35(4): p. 525-32. |
| Unit | Bottle |
| Specification | 10mM*1mL in DMSO 50mg 100mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download